Related references
Note: Only part of the references are listed.Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma
Guillermo de Velasco et al.
BRITISH JOURNAL OF CANCER (2018)
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
Samra Turajlic et al.
CELL (2018)
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
Thomas J. Mitchell et al.
CELL (2018)
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
Samra Turajlic et al.
CELL (2018)
Relationship of tumor mutational burden (TMB) to immunotherapy response in metastatic renal cell carcinoma (mRCC).
Manuel C. Maia et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Diana Miao et al.
SCIENCE (2018)
Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management
Eamonn R. Maher
WORLD JOURNAL OF UROLOGY (2018)
Prognostic factors and prognostic models for renal cell carcinoma: a literature review
Tobias Klatte et al.
WORLD JOURNAL OF UROLOGY (2018)
Epidemiology and screening for renal cancer
Sabrina H. Rossi et al.
WORLD JOURNAL OF UROLOGY (2018)
Systemic therapy in metastatic renal cell carcinoma
Jens Bedke et al.
WORLD JOURNAL OF UROLOGY (2017)
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
James J. Hsieh et al.
EUROPEAN UROLOGY (2017)
Genome-wide association study identifies multiple risk loci for renal cell carcinoma
Ghislaine Scelo et al.
NATURE COMMUNICATIONS (2017)
HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas
Mianen Sun et al.
CANCER RESEARCH (2017)
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
Jozefina Casuscelli et al.
JCI INSIGHT (2017)
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
David J. Kwiatkowski et al.
CLINICAL CANCER RESEARCH (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
W. Marston Linehan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
SETD2: an epigenetic modifier with tumor suppressor functionality
Jun Li et al.
ONCOTARGET (2016)
How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma?
Aspasia Soultati et al.
CURRENT OPINION IN UROLOGY (2015)
Clock-like mutational processes in human somatic cells
Ludmil B. Alexandrov et al.
NATURE GENETICS (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC)
Christopher J. Ricketts et al.
PLOS ONE (2015)
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution
Michal Kovac et al.
NATURE COMMUNICATIONS (2015)
The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis
Shilpy Joshi et al.
CELL REPORTS (2015)
TERT promoter mutations in clear cell renal cell carcinoma
Ismail Hosen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery
I. El-Mokadem et al.
BRITISH JOURNAL OF CANCER (2014)
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Caleb F. Davis et al.
CANCER CELL (2014)
Cancer-Associated PTEN Mutants Act in a Dominant-Negative Manner to Suppress PTEN Protein Function
Antonella Papa et al.
CELL (2014)
Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy
Martin H. Voss et al.
CLINICAL CANCER RESEARCH (2014)
Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
Sakshi Gulati et al.
EUROPEAN UROLOGY (2014)
Prognostic Significance of Biallelic Loss of PTEN in Clear Cell Renal Cell Carcinoma
Hee Jin Lee et al.
JOURNAL OF UROLOGY (2014)
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
Marco Gerlinger et al.
NATURE GENETICS (2014)
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers
Eric C. Kauffman et al.
NATURE REVIEWS UROLOGY (2014)
Variation in genomic landscape of clear cell renal cell carcinoma across Europe
Ghislaine Scelo et al.
NATURE COMMUNICATIONS (2014)
TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas
Kun Wang et al.
ONCOTARGET (2014)
SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint
Silvia Carvalho et al.
ELIFE (2014)
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling
Alexander Sankin et al.
CANCER MEDICINE (2014)
Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma
Nils Kroeger et al.
CANCER (2013)
Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
A. Ari Hakimi et al.
CLINICAL CANCER RESEARCH (2013)
Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer
Marc Henrion et al.
HUMAN MOLECULAR GENETICS (2013)
Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma
Toni K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
Payal Kapur et al.
LANCET ONCOLOGY (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato et al.
NATURE GENETICS (2013)
mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin
Seong A. Kang et al.
SCIENCE (2013)
A common variant at 8q24.21 is associated with renal cell cancer
Julius Gudmundsson et al.
NATURE COMMUNICATIONS (2013)
Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma
Tobias Klatte et al.
CANCER (2012)
A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23
Xifeng Wu et al.
HUMAN MOLECULAR GENETICS (2012)
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma
Guangwu Guo et al.
NATURE GENETICS (2012)
BAP1 loss defines a new class of renal cell carcinoma
Samuel Pena-LlopiS et al.
NATURE GENETICS (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela et al.
NATURE (2011)
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3
Mark P. Purdue et al.
NATURE GENETICS (2011)
Genetic and Functional Studies Implicate HIF1α as a 14q Kidney Cancer Suppressor Gene
Chuan Shen et al.
CANCER DISCOVERY (2011)
p16 Modulates VEGF Expression via Its Interaction With HIF-1α in Breast Cancer Cells
Jun Zhang et al.
CANCER INVESTIGATION (2010)
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Gillian L. Dalgliesh et al.
NATURE (2010)
Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma
Tobias Klatte et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Genetic and epigenetic alterations in the von Hippel-Lindau gene: The influence on renal cancer prognosis
Kim M. Smits et al.
CLINICAL CANCER RESEARCH (2008)
Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma
Jean-Jacques Patard et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Family history and the risk of kidney cancer: A multicenter case-control study in Central Europe
Rayjean J. Hung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Share Paper
